Chapel Hill, NC, United States of America

Michael J Cory


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 1983

Loading Chart...
1 patent (USPTO):Explore Patents

Title: A Look at Inventor Michael J Cory and His Innovations in Radiosensitizers

Introduction: Michael J Cory, a notable inventor based in Chapel Hill, NC, has made significant contributions to the field of cancer treatment through his inventive work. With a focus on developing compounds that enhance the effectiveness of radiation therapy, he has earned recognition in the scientific community.

Latest Patents: Cory holds a patent for "Nitroimidazoles of low toxicity and high activity as radiosensitizers." This innovation describes two compounds characterized by a specific formula, where R can be hydrogen or a 2-hydroxyethyl radical. These compounds exhibit minimal penetration into brain and nerve tissues while maximizing penetration into hypoxic tumor cells. This unique combination of properties positions these compounds as optimal radiosensitizers among electron-affinic 1-substituted 2-nitroimidazoles, making them crucial in the battle against cancer.

Career Highlights: Michael J Cory works for the United States of America, as represented by the Secretary of Health and Human Services. Throughout his career, he has dedicated his efforts to scientific research and innovation, contributing to advancements in medical technology and treatment strategies, specifically targeting cancer therapies.

Collaborations: Throughout his work, Cory has collaborated with esteemed colleagues such as William W Lee and J Martin Brown. Their combined expertise has been instrumental in enhancing the research and development of innovative medical treatments, further advancing the field of radiology and cancer treatment.

Conclusion: Michael J Cory is an influential figure in the realm of medical inventions, particularly in the development of radiosensitizers. His patent represents a significant step forward in cancer treatment, showcasing his commitment to improving patient outcomes through innovative research and collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…